Global Systemic Lupus Erythematosus (SLE) Drugs Industry Growth and Trends Forecast to 2032

Types

• BLyS-Specific Inhibitors or Monoclonal Antibodies (MAbS)
• Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
• Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
• Anticoagulants
• Antimalarials
• Immunosuppressive Agents/Immune Modulators
• Corticosteroids
• Anti-Inflammatories

Applications

• Intravenous
• Topical
• Oral
• Sub-Cutaneous

Key Companies